- Report
- October 2024
- 70 Pages
France
From €903EUR$950USD£759GBP
- Report
- October 2024
- 70 Pages
Germany
From €903EUR$950USD£759GBP
- Report
- October 2024
- 70 Pages
India
From €903EUR$950USD£759GBP
- Report
- October 2024
- 70 Pages
Japan
From €903EUR$950USD£759GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €903EUR$950USD£759GBP
- Report
- October 2024
- 70 Pages
United States
From €903EUR$950USD£759GBP
- Report
- January 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- April 2022
- 220 Pages
Global
From €3285EUR$3,456USD£2,760GBP
The Congestive Heart Failure Device market is a subset of the Cardiovascular Devices market. It includes a range of devices used to treat congestive heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These devices include implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and left ventricular assist devices (LVADs). These devices are designed to improve the quality of life of patients with congestive heart failure by providing support to the heart and helping to regulate its rhythm.
Some of the major companies in the Congestive Heart Failure Device market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and LivaNova. Show Less Read more